2015
The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-kappa B
ANEES, Mariam; Peter HORAK; Ana-Iris SCHIEFER; Petr VAŇHARA; Ahmed EL-GAZZAR et al.Základní údaje
Originální název
The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-kappa B
Autoři
ANEES, Mariam; Peter HORAK; Ana-Iris SCHIEFER; Petr VAŇHARA; Ahmed EL-GAZZAR; Paul PERCO; Barbara KIESEWETTER; Leonhard MÜLLAUER; Berthold STREUBEL; Markus RADERER a Krainer MICHAEL
Vydání
Leukemia & Lymphoma, London, Informa Healthcare, 2015, 1042-8194
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 3.093
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/15:00082176
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
MALT lymphoma; TRAIL; NF-kappa B; DcR2
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 24. 7. 2015 13:18, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
This study investigated expression profiles of tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL) pathway components and mechanisms underlying TRAIL-induced apoptosis in mucosa associated lymphoid tissue (MALT) lymphoma. Genetic aberrations including translocations and trisomies were assessed by reverse transcription polymerase chain reaction and fluorescence in situ hybridization. Expression of TRAIL, death receptors 4 and 5, decoy receptors 1 and 2, and FADD-like interleukin-1 b -converting enzyme (FLICE) inhibitory protein was analyzed by immunohistochemistry. All 32 patients under study showed some alterations in TRAIL pathway mainly involving loss of death receptors (37.5%), gain of decoy receptors (3.1%) or both (59.4%). Decoy receptor 2 (DcR2) was highly expressed in patients with normal cytogenetic status as compared to those with cytogenetic aberrations ( p=0.005). Moreover, DcR2 expression correlated signifi cantly with nuclear factor-kappa B (NF- kappa B) expression ( R=0.372, p= 0.047). High expression of DcR2 in patients with normal cytogenetic status and its significant correlation with NF- kappa B expression provides a potential clue to evasion of immune surveillance in cytogenetically normal MALT lymphomas.